comparemela.com
  1. Home
  2. Live Updates
  3. Salt Inducible Kinase - Breaking News

Latest Breaking News On - Salt inducible kinase - Page 1 : comparemela.com

Rhizen Pharmaceuticals AG Announces Promising Interim Data Presentation From an Ongoing Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients At ESMO Breast Cancer Meeting 2022

Rhizen Pharma reports encouraging initial results from an ongoing phase II trial to evaluate Tenalisib (RP6530; isoform selective dual PI3K d/? inhibitor with additional SIK3 inhibitory activity)

Samyukta bhagwatiKostenloser wertpapierhandelSwaroop vakkalankaRhizen pharmaRhizen pharmaceuticalsRhizen pharmaceuticals ag contactRhizen pharmaceuticals agCorporate affairs communicationsCancer meetingSalt inducible kinaseTrack orphan drug designations

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.